drugset / Trial / NCT00971308
Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the antiviral effect following three days of dosing with BMS-824393 in chronically genotype subtype 1a and 1b Hepatitis C virus (HCV) infected subjects.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-08
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-824393 | Unknown | 1 mg | Oral |
| Subject | BMS-824393 | Unknown | 10 mg | Oral |
| Subject | BMS-824393 | Unknown | 50 mg | Oral |
| Subject | BMS-824393 | Unknown | 100 mg | Oral |